3
30
FELASA Working Group on Animal Health
specific infection, a variety of biological
parameters may be affected such as
of these investigations should be
reported.
behaviour, growth rate, relative organ
1
.2 These recommendations are intended
for the selection and purchase of small
ruminants (e.g. calves, sheep and goatsl
for use in biomedical research.
weights, immune response, tumour develop-
ment, etc. Subclinical infections can also
lead to contamination of biological materials,
tissue cultures, transplantable tumours and
biological products. All infections, apparent
or inapparent, are likely to increase biological
variability. In addition, some animal infec-
tions are zoonotic, i.e. transmissible to man.
For all these reasons, animal health moni-
toring programmes are important, adding to
the reliability and reproducibility of research
data and decreasing the risk for researchers
and staff of contracting zoonotic infections.
These recommendations propose health
monitoring programmes for small ruminants,
defined as calves, sheep and goats, used in
biomedical research, with the intention of
harmonizing procedures and achieving simi-
lar standards of testing within the FELASA
member countries. It is recognized that the
wide variety in animal sources, husbandry
practices, local and national animal health
regulations and standards will lead to more
variations in health status and monitoring
requirements than encountered with com-
mon laboratory species such as rodents. A
major goal of these recommendations is to
ensure that health monitoring reports have a
common standard and format, identifying the
presence or absence of specific pathogens in
laboratory animal colonies.
1.3 The specialized breeding of small rumi-
nants for scientific purposes is an
exception, and calves, sheep and goats
are usually purchased from farms with
traditional agricultural production. The
standard and suitability of the premises
on farms selected for the breeding of
small ruminants intended for use in
biomedical investigations, as well as the
health ofthe animals being bred, must be
regularly monitored (at least two vis-
its/year) and the results recorded. All
dead and aborted animals should be
necropzied and the results incorporated
in records kept for inspection.
1
.4 These recommendations are also
intended for experimental colonies and
units where calves, sheep and goats are
kept and used for biomedical research.
1.5 Each unit, farm or experimental colony
being monitored is considered to be a
separate microbiological entity.
1
.6 Detailed written procedures-Standard
Operating Procedures (SOPs)-within
monitoring laboratories must be
available.
1
.7 Monitoring laboratories should follow
quality procedures, such as FELASA's
scheme (Hornberger et ai. 1999), Good
Laboratory Practice or national animal
health diagnostic laboratory schemes.
1. General considerations
1
.1 Depending on local conditions, the
number of agents to be monitored will
vary from country to country. Diseases
declared, by a national authority, to be
absent in a certain country or region
do not need to be monitored. Actual
practice may exceed these recommen-
dations in various ways, depending on
local circumstances-for example the
regional prevalence of specific organ-
isms, the intended use of progeny or the
existence of national monitoring
1
.8 An agent must be declared as present if
it is identified. It should be emphasized
that negative results mean only that the
presence of the pathogens monitored
has not been demonstrated in the
animals screened by the test(s) used.
The results are not necessarily a
reflection of the status of all the
animals in the unit.
schemes. Additional investigations
may be deemed necessary. The results
1.9 The presence of antibodies against
organisms for which the animals have
Laboratory Animals (2000) 34